Table 5.
Parameters | Illicit drugs | Species | References | ||||
---|---|---|---|---|---|---|---|
Semen | Free radicals | Decreased antioxidant capability | Opioids | Human | Safarinejad et al. (38) | ||
Increased ROS | Morphine | Human (cell line) | Safarinejad et al. (38), Ma et al. (74) | ||||
Sperm plasma membrane |
ᵟ ,ᵏ, and µ receptors | Decreased sperm motility | Agonist of µ receptors | Morphine | Human (in vitro) | Agirregoitia et al. (76) | |
Heroin | Human | Nazmara et al. (53), Rezaei-Mojaz et al. (70) | |||||
Antagonist of ᵟ receptors | Naltrindole | Human | Agirregoitia et al. (76) | ||||
Increased sperm motility | Antagonist of µ receptors |
Naloxone | Human | Agirregoitia et al. (76) | |||
Enkephalin degrading enzymes | Decreased aminopeptidase N (mRNA, Protein) |
Heroin | Human | Rezaei-Mojaz et al. (70) | |||
Decreased enkephalinase (mRNA) | Heroin | Human | Rezaei-Mojaz et al. (70) | ||||
Decreased expression of CatSper 1 - 4 mRNAs | Iranian Kerack | Mice | Amini et al. (69) | ||||
Sperm nucleus | Histone-to-protamine Transition deficiency | Heroin | Human | Nazmara et al. (53) | |||
Increased DFI % | Opioids | Human | Safarinejad et al. (38) | ||||
Decreased protamine-2 (mRNA and Protein) | Heroin | Human | Nazmara et al. (11) | ||||
Increased HDAC1 | Heroin | Human | Nazmara et al. (85) | ||||
Decreased HDAC11 | Heroin | Human | Nazmara et al. (85) | ||||
Increased miR-122 | Heroin | Human | Nazmara et al. (11) | ||||
Decreased miR-125b-5p | Heroin | Human | Nazmara et al. (11) |